Región Metropolitana de Santiago
Este organismo compró $35.329.096.472 en 11.633 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $1367,1 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-95-AG26 | 18-02-2026 | Pharmaxpress SpA | Recepcion Conforme | $1.414.910 |
| 2980-96-AG26 | 18-02-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $738.347 |
| 2980-97-AG26 | 18-02-2026 | Bayer S.A. | Recepcion Conforme | $6.735.909 |
| 2980-98-AG26 | 18-02-2026 | Synthon Chile Limitada | Recepcion Conforme | $303.404 |
| 2980-99-AG26 | 18-02-2026 | Carbow Labs SpA | Recepcion Conforme | $1.785.000 |
| 2980-107-AG26 | 18-02-2026 | Astrazeneca S.A. | Recepcion Conforme | $4.955.084 |
| 2980-108-AG26 | 18-02-2026 | Astrazeneca S.A. | Recepcion Conforme | $6.129.404 |
| 2980-109-AG26 | 18-02-2026 | Dr. Reddys Laboratories Chile SpA | Recepcion Conforme | $963.900 |
| 2980-111-AG26 | 18-02-2026 | Astrazeneca S.A. | Recepcion Conforme | $6.129.404 |
| 2980-112-AG26 | 18-02-2026 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | Recepcion Conforme | $110.741 |
| 2980-113-AG26 | 18-02-2026 | Comercializadora de Equipos Computacionales y Telecomunicaciones Dictel SpA | Recepcion Conforme | $237.976 |
| 2980-110-AG26 | 18-02-2026 | Novartis Chile S.A. | Cancelada | $4.797.323 |
| 2980-76-TD26 | 12-02-2026 | Comercial e Industrial Mag Limitada | Recepcion Conforme | $6.919.850 |
| 2980-101-SE26 | 12-02-2026 | Fundacion Dr Jorge Perez Rifo | Aceptada | $18.769.039 |
| 2980-102-SE26 | 12-02-2026 | Fundacion Dr Jorge Perez Rifo | Aceptada | $2.209.634 |
| 2980-103-SE26 | 12-02-2026 | Fundacion Dr Jorge Perez Rifo | Aceptada | $18.065.651 |
| 2980-104-SE26 | 12-02-2026 | Fundacion Dr Jorge Perez Rifo | Aceptada | $3.122.959 |
| 2980-105-SE26 | 12-02-2026 | Fundacion Dr Jorge Perez Rifo | Aceptada | $11.392.223 |
| 2980-106-SE26 | 12-02-2026 | Fundacion Dr Jorge Perez Rifo | Aceptada | $858.881 |
| 2980-100-TD26 | 11-02-2026 | Ecoclima SpA | Recepcion Conforme | $1.745.730 |
| 2980-67-AG26 | 06-02-2026 | Synthon Chile Limitada | Recepcion Conforme | $1.799.280 |
| 2980-68-AG26 | 04-02-2026 | Varifarma Chile SpA | Recepcion Conforme | $856.800 |
| 2980-69-AG26 | 04-02-2026 | Gador Limitada | Recepcion Conforme | $2.106.300 |
| 2980-70-AG26 | 04-02-2026 | Gador Limitada | Recepcion Conforme | $3.207.050 |
| 2980-71-AG26 | 04-02-2026 | Novofarma Service S.A. | Recepcion Conforme | $4.170.355 |
| 2980-72-AG26 | 04-02-2026 | Synthon Chile Limitada | Recepcion Conforme | $6.283.200 |
| 2980-73-AG26 | 04-02-2026 | Laboratorios Elea Chile SpA | Recepcion Conforme | $3.480.750 |
| 2980-74-AG26 | 04-02-2026 | Synthon Chile Limitada | Recepcion Conforme | $373.184 |
| 2980-66-AG26 | 02-02-2026 | Pro Sales Diego Torneria EIRL | Recepcion Conforme | $1.018.521 |
| 2980-64-AG26 | 30-01-2026 | Alembic Pharmaceuticals SpA | Recepcion Conforme | $4.789.512 |
